NAD+ Boosters (NMN, NR): Honestly Graded
NAD+ boosters like NMN and NR reliably raise the NAD+ biomarker in human trials, that part of the claim is strong. The leap from there to reversed aging or a longer life is not supported by any published human trial: those results come from worms, flies, and mice. Treat any booster as an experiment layered on top of the proven basics (sleep, strength training, not smoking, whole foods), not a replacement for them, and talk to your doctor before starting one.
Understand the mechanism NMN and NR are precursor molecules the body converts into NAD+, a coenzyme every cell needs for energy metabolism and DNA repair; NAD+ levels decline with age.
This is why boosting the precursor is the proposed mechanism; a plausible mechanism is not the same as a proven outcome.
See what the best human trial actually showed In an 8-week, 140-person randomized trial, the highest tested dose of NR raised whole-blood NAD+ by up to 142% within 2 weeks, sustained through 8 weeks, with no significant safety signal versus placebo.
That is strong evidence the biomarker moves. It is not evidence of a health outcome.
Look at the small trials that measured an actual outcome Trials measuring functional endpoints are small and short. An NMN trial (n=14, 250mg/day, 24 weeks) was safe but found no walking-speed improvement; a 12-week NR trial in mild cognitive impairment showed mixed results.
Safe at studied doses, but the human functional evidence is modest and inconsistent, not a demonstrated health benefit.
Separate the biomarker from the aging claim No published human trial has shown a lifespan or hard clinical-outcome benefit from any NAD+ booster. The reverse-aging results people cite are from worms, flies, and mice.
Tier C: plausible mechanism, unproven in people.
Spend on the proven levers first Before spending on any NAD+ booster, the proven cheap longevity levers come first: sleep, 2+ strength sessions a week, not smoking, whole foods. If you still try a booster, treat it as an experiment, not a cure.
A marker moving is not proof of a longer or healthier life.
The strongest human data here is narrow: an 8-week, 140-person randomized trial found the highest tested dose of NR raised whole-blood NAD+ by up to 142% within two weeks, sustained through eight weeks, with no significant safety signal versus placebo.
View sources
FoundMyFitness (Rhonda Patrick): NAD+ in Aging, Role of Nicotinamide Riboside and Nicotinamide Mononucleotide
NAD+ in Aging: Role of Nicotinamide Riboside and Nicotinamide Mononucleotide (FoundMyFitness)
NAD+ infusions, supplements and the science of longevity
Conze D, Crusemann C, Kruger C, et al., Nicotinamide riboside raises NAD+ in a dose-dependent manner, Scientific Reports 9:9772 (2019)
NMN and walking speed, randomized controlled trial (n=14, 250mg/day, 24 weeks)
Nicotinamide riboside in mild cognitive impairment, 12-week randomized controlled trial
Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.
Is this for you
- Anyone curious about NMN or NR supplements who wants the real evidence, not marketing
- Longevity-curious readers deciding whether an NAD+ booster is worth the cost
- Readers who want the biomarker claim separated from the anti-aging claim
Cautions
- Educational only, not medical advice; talk to your doctor before starting any supplement, especially with existing conditions or medications
- A marker moving (NAD+ levels) is not proof of a longer or healthier life
- No published human trial has shown a lifespan or hard clinical-outcome benefit from any NAD+ booster
- Trials cited here are short (8 to 24 weeks); no long-term human safety or efficacy data exists